In a CARACAL meeting, the European Commission has introduced the latest update of the ‘Rolling List of (groups of) substances for restriction’, which is part of the Restrictions Roadmap. HEAL has provided feedback to the updated rolling list and note concerns on the repeated delays in the implementation of restrictions of groups of substances that have been included in the Roadmap for several years.
HEAL has responded to the call for evidence on the Industrial Decarbonisation Accelerator Act – find the full response.
Related Posts
The European Commission is currently evaluating the Cosmetic Products Regulation. HEAL has submitted our input to the public consultation and highlight for example the importance of the regulation for the protection of EU citizens from substances that can affect hormone-driven processes. This evaluation initiative runs in parallel to the discussions on the Cosmetic Products Regulation as part of the Sixth Omnibus proposal from the European Commission.
HEAL has submitted comments to the proposals for two ongoing risk management procedures on two brominated flame retardants: namely decabromodiphenyl ethane (DBDPE) and bis(2-ethylhexyl) tetrabromophthalate (TBPH).
